Kiromic Biopharma

Bioinformatics, Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics

Founded in 1/1/12

Houston, Texas, United States

http://www.kiromic.com

For Profit

About Kiromic Biopharma

Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Their cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times.

Company Metrics

Employees: 51-100
Monthly Visits: 2082
Tech Stack: 15 active products

Financial Information

Estimated Revenue: Less than $1M
Total Funding: 63244888 USD
Last Funding: 8000000 USD (Post-IPO Equity)
Funding Status: IPO

Technology Stack

Kiromic Biopharma actively uses 15 products in their tech stack.

Market Presence

Industries: Bioinformatics, Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics

Headquarters: Houston, Texas, United States

Employees